You can buy or sell PRAH and other stocks, options, and ETFs commission-free!
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. The listed name for PRAH is PRA Health Sciences, Inc. Common Stock.
Raleigh, North Carolina
52 Week High
52 Week Low
Icon eyes growing virtual clinical trial market with $12 billion PRA Health deal
(Reuters) - Icon Plc said on Wednesday it will buy rival PRA Health Sciences Inc in a deal valued at about $12 billion, to create a contract drug research firm
$1.47 per share
Available Feb 25, After Hours